Northern Trust’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22,231
| Closed | -$18.1K | – | 4602 |
|
|
2023
Q3 | $18.1K | Hold |
22,231
| – | – | ﹤0.01% | 4344 |
|
|
2023
Q2 | $20.5K | Hold |
22,231
| – | – | ﹤0.01% | 4408 |
|
|
2023
Q1 | $16.9K | Sell |
22,231
-320
| -1% | -$631 | ﹤0.01% | 4475 |
|
|
2022
Q4 | $56.6K | Hold |
22,551
| – | – | ﹤0.01% | 4253 |
|
|
2022
Q3 | $31K | Buy |
22,551
+3,145
| +16% | +$4.55K | ﹤0.01% | 4456 |
|
|
2022
Q2 | $24K | Buy |
19,406
+268
| +1% | +$561 | ﹤0.01% | 4597 |
|
|
2022
Q1 | $55K | Sell |
19,138
-344
| -2% | -$830 | ﹤0.01% | 4514 |
|
|
2021
Q4 | $44K | Buy |
19,482
+2,822
| +17% | +$6.55K | ﹤0.01% | 4613 |
|
|
2021
Q3 | $43K | Sell |
16,660
-3,012
| -15% | -$7.64K | ﹤0.01% | 4555 |
|
|
2021
Q2 | $57K | Sell |
19,672
-4,295
| -18% | -$12.4K | ﹤0.01% | 4473 |
|
|
2021
Q1 | $75K | Sell |
23,967
-3,381
| -12% | -$11.5K | ﹤0.01% | 4334 |
|
|
2020
Q4 | $72K | Sell |
27,348
-3,735
| -12% | -$10K | ﹤0.01% | 4181 |
|
|
2020
Q3 | $90K | Buy |
31,083
+814
| +3% | +$2.63K | ﹤0.01% | 3986 |
|
|
2020
Q2 | $103K | Sell |
30,269
-35,885
| -54% | -$101K | ﹤0.01% | 3912 |
|
|
2020
Q1 | $132K | Sell |
66,154
-8,888
| -12% | -$32.6K | ﹤0.01% | 3764 |
|
|
2019
Q4 | $301K | Sell |
75,042
-1,752
| -2% | -$5.95K | ﹤0.01% | 3675 |
|
|
2019
Q3 | $246K | Buy |
76,794
+28,481
| +59% | +$83.5K | ﹤0.01% | 3707 |
|
|
2019
Q2 | $188K | Buy |
48,313
+9,491
| +24% | +$181K | ﹤0.01% | 3838 |
|
|
2019
Q1 | $944K | Buy |
38,822
+5,250
| +16% | +$124K | ﹤0.01% | 3378 |
|
|
2018
Q4 | $676K | Buy |
33,572
+1,797
| +6% | +$41.4K | ﹤0.01% | 3477 |
|
|
2018
Q3 | $980K | Buy |
+31,775
| New | +$851K | ﹤0.01% | 3474 |
|
|
2015
Q3 | – | Sell |
-442
| Closed | -$16K | – | 4343 |
|
|
2015
Q2 | $16K | Sell |
442
-99
| -18% | -$3.81K | ﹤0.01% | 4156 |
|
|
2015
Q1 | $25K | Hold |
541
| – | – | ﹤0.01% | 4213 |
|
|
2014
Q4 | $32K | Hold |
541
| – | – | ﹤0.01% | 4145 |
|
|
2014
Q3 | $45K | Hold |
541
| – | – | ﹤0.01% | 4156 |
|
|
2014
Q2 | $75K | Hold |
541
| – | – | ﹤0.01% | 4056 |
|
|
2014
Q1 | $84K | Hold |
541
| – | – | ﹤0.01% | 3983 |
|
|
2013
Q4 | $82K | Buy |
541
+103
| +24% | +$16.8K | ﹤0.01% | 3901 |
|
|
2013
Q3 | $80K | Buy |
438
+303
| +224% | +$40.5K | ﹤0.01% | 3852 |
|
|
2013
Q2 | $17K | Buy |
+135
| New | +$19.7K | ﹤0.01% | 4016 |
|
Other funds holding ACER
Northern Trust's ACER Position: Q4 2023 in Review
Northern Trust sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 22,231 shares — an estimated $18.1K sold.
Northern Trust first reported a position in ACER in Q2 2013 and held it in 30 quarters. The position peaked at $980K in Q3 2018. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- Northern Trust reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- Northern Trust sold 22,231 Acer Therapeutics Inc shares in Q4 2023, an estimated $18.1K.
- Northern Trust first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 30 quarters.
- Northern Trust's Acer Therapeutics Inc position peaked at $980K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.